Subgroup analyses from READY: Real-world data from an Italian compassionate use program (CUP) of avelumab first-line maintenance (1LM) treatment for locally advanced or metastatic urothelial carcinoma (la/mUC)

被引：2

作者：

Bracarda, Sergio ^{[1
]}

Antonuzzo, Lorenzo ^{[2
]}

Maruzzo, Marco ^{[3
]}

Santini, Daniele ^{[4
]}

Tambaro, Rosa ^{[5
]}

Buti, Sebastiano ^{[6
]}

Carrozza, Francesco ^{[7
,8
]}

Calabro, Fabio

Di Lorenzo, Giuseppe ^{[9
]}

Fornarini, Giuseppe ^{[10
]}

Iacovelli, Roberto ^{[11
]}

Cullura, Daniela ^{[12
]}

Messina, Carlo ^{[13
]}

Cerbone, Linda ^{[14
]}

Fazzi, Gennaro ^{[15
]}

Venturini, Filippo ^{[15
]}

Colasanto, Raffaele ^{[15
]}

Necchi, Andrea ^{[16
]}

De Giorgi, Ugo ^{[17
]}

机构：

[1] Azienda Osped Santa Maria, Terni, Italy

[2] Azienda Osped Univ Careggi, Florence, Italy

[3] IOV IRCCS, Ist Oncol Veneto, Padua, Italy

[4] Univ Sapienza Polo Pontino, Rome, Italy

[5] Ist Nazl Tumori IRCCS Fdn G Pascale, Naples, Italy

[6] Univ Parma, Parma, Italy

[7] AUSL Romagna, Ravenna, Italy

[8] IFO Ist Regina Elena, Rome, Italy

[9] ASL SALERNO PO A Tortora, Pagani, Italy

[10] IRCCS Osped Policlin San Martino, Genoa, Italy

[11] Fdn Policlin Univ A Gemelli IRCCS, Rome, Italy

[12] Ist Europeo Oncol IEO, Milan, Italy

[13] Osped ARNAS Civ, Palermo, Italy

[14] Azienda Osped San Camillo Forlanini, Rome, Italy

[15] Merck Serono SPA, Merck KGaA, Rome, Italy

[16] IRCCS San Raffaele Hosp & Sci Inst, Milan, Italy

[17] IRCCS, Ist Romagnolo Studio Tumori IRST Dino Amadori, Meldola, Italy

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 4_SUPPL期

关键词：

D O I：

10.1200/JCO.2024.42.4_suppl.558

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：558 / 558

页数：1

共 50 条

[21] BUDGET IMPACT ANALYSIS OF AVELUMAB plus BEST SUPPORTIVE CARE (BSC) AS FIRST-LINE MAINTENANCE TREATMENT IN PATIENTS WITH LOCALLY ADVANCED OR METASTATIC UROTHELIAL CARCINOMA (LA/MUC) IN IRELAND
Russell, L.
Christoforou, K.
McAlister, M.
Alexopoulos, S.
Bullement, A.
VALUE IN HEALTH, 2022, 25 (12) : S140 - S140
[22] COST-EFFECTIVENESS ANALYSIS OF AVELUMAB PLUS BEST SUPPORTIVE CARE (BSC) AS FIRST-LINE MAINTENANCE TREATMENT IN LOCALLY ADVANCED OR METASTATIC UROTHELIAL CARCINOMA (LA/MUC) IN FRANCE
Plessala, I
Cawston, H.
Roiz, J.
Xiao, Y.
Kearney, M.
Chang, J.
Porte, F.
Granghaud, A.
Morel, A.
Ravaud, A.
Loriot, Y.
Thiery-Vuillemin, A.
Levy, P.
VALUE IN HEALTH, 2022, 25 (12) : S113 - S113
[23] Avelumab first-line (1L) maintenance therapy in advanced urothelial carcinoma: Final analysis from a real-world study in the UK.
Jones, Robert Jones
Shah, Yatri
Birtle, Alison Jane
Challapalli, Amarnath
Chan, Joachim
Enting, Deborah
Hudson, Andrew
Linch, Mark David
Otter, Sophie
Protheroe, Andrew
Sharma, Anand
Turner, Rufus
Chengat Prakashbabu, Bhagyalakshmi
Rice, Wendy
Jedy-Agba, Elima Enaji
JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (5_SUPPL)
[24] Full analysis from AVENANCE: A real-world study of avelumab first-line (1L) maintenance treatment in patients (pts) with advanced urothelial carcinoma (aUC).
Barthelemy, Philippe
Loriot, Yohann
Voog, Eric
Eymard, Jean Christophe
Ravaud, Alain
Flechon, Aude
Jaillon, Christine Abraham
Chasseray, Matthieu
Lorgis, Veronique
Hilgers, Werner
Gobert, AurElien
Le Moulec, Sylvestre
Simon, Camille
Nicolas, Emanuel
Escande, Anne
Pouessel, Damien
Josse, Constant
Solbes, Marie-Noelle
Lambert, Prisca
Thibault, Constance
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
[25] Avenue: A prospective observational study of real-world treatment patterns and treatment outcomes in patients with advanced or metastatic urothelial carcinoma treated with avelumab first-line maintenance therapy
Gschwend, J.
Belz, H.
Boegemann, M.
Niegisch, G.
Janssen, J.
Henrici, M.
Schostak, M.
Gruenwald, V
Wille, K.
Wunderlich, H.
Schlack, K.
Stark, L.
Mundel, T.
Grimm, M. O.
ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 : 266 - 266
[26] Maintenance therapy with avelumab as the first-line treatment in patients with metastatic urothelial carcinoma: A real-world, ambispective RAVE-Bladder study.
Gridneva, Yana
Sultanbaev, Alexander, Sr.
Anzhiganova, Yulia
Gluzman, Mark
Mochalova, Anastasia
Shkurat, Alexey
Parsadanova, Elvira
Israelyan, Edgar
Murzina, Yulia
Kalpinsky, Aleksey
Stativko, Olesia
Karabina, Elena
Kfln, Artyom
Petkau, Vladislav
Tovbik, Natalya
Turganova, Maria
Safina, Sufiia
Kopyltsov, Evgeny
Volkova, Maria
Tsimafeyeu, Ilya
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
[27] Real-world first-line treatment patterns and outcomes in patients with locally advanced or metastatic urothelial carcinoma in the United States.
Chen, Ronald C.
Mucha, Lisa
Nimke, David
Young, Christopher
Yang, Hongbo
Liu, Qing
Greatsinger, Alexandra
Zhang, Adina
Wright, Phoebe
Quicquaro, Christina Marie
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
[28] Switch-maintenance avelumab immunotherapy following first-line chemotherapy for patients with advanced, unresectable or metastatic urothelial carcinoma: the first Japanese real-world evidence from a multicenter study
Miyake, Makito
Shimizu, Takuto
Oda, Yuki
Tachibana, Akira
Ohmori, Chihiro
Itami, Yoshitaka
Kiba, Keisuke
Tomioka, Atsushi
Yamamoto, Hiroaki
Ohnishi, Kenta
Nishimura, Nobutaka
Hori, Shunta
Morizawa, Yosuke
Gotoh, Daisuke
Nakai, Yasushi
Torimoto, Kazumasa
Fujii, Tomomi
Tanaka, Nobumichi
Fujimoto, Kiyohide
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2023, 53 (03) : 253 - 262
[29] Avelumab first-line maintenance (1LM) for advanced urothelial carcinoma (aUC): Long-term outcomes from JAVELIN Bladder 100 in patients (pts) with low tumor burden
Bellmunt, Joaquim
Powles, Thomas
Park, Se Hoon
Voog, Eric
Valderrama, Begona Perez
Gurney, Howard
Ullen, Anders
Loriot, Yohann
Sridhar, Srikala S.
Tsuchiya, Norihiko
Sternberg, Cora N.
Aragon-Ching, Jeanny B.
Petrylak, Daniel P.
Duran, Miguel A. Climent
Tyroller, Karin
Hoffman, Jason
Jacob, Natalia
Grivas, Petros
Gupta, Shilpa
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
[30] Avelumab First-line Maintenance Therapy for Advanced Urothelial Carcinoma: Comprehensive Clinical Subgroup Analyses from the JAVELIN Bladder 100 Phase 3 Trial
Grivas, Petros
Park, Se Hoon
Voog, Eric
Caserta, Claudia
Gurney, Howard
Bellmunt, Joaquim
Kalofonos, Haralabos
Ullen, Anders
Loriot, Yohann
Sridhar, Srikala S.
Yamamoto, Yoshiaki
Petrylak, Daniel P.
Sternberg, Cora N.
Gupta, Shilpa
Huang, Bo
Costa, Nuno
Laliberte, Robert J.
di Pietro, Alessandra
Valderrama, Begona P.
Powles, Thomas
EUROPEAN UROLOGY, 2023, 84 (01) : 95 - 108

← 1 2 3 4 5 →